InflaRx N.V. Total Non Current Liabilities 2011-2026 | IFRX

Annual Total Non Current Liabilities InflaRx N.V.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	254 K	370 K	67 K	17 K	53.5 M	20.8 M	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
53.5 M	17 K	12.5 M

Quarterly Total Non Current Liabilities InflaRx N.V.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	1.1 M	-	-	-	254 K	-	-	-	370 K	-	698 K	-	67.9 K	-	-	-	17 K	-	-	-	53.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
53.5 M	17 K	8 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Cerus Corporation CERS	58.1 M	$ 2.61	28.62 %	$ 497 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	341 M	$ 97.03	-6.21 %	$ 27.2 B	Germany
I-Mab IMAB	131 M	-	-	$ 866 M	China
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	49.6 M	$ 21.91	-2.41 %	$ 3.63 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
Cardiff Oncology CRDF	451 K	$ 1.72	-0.87 %	$ 115 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Caladrius Biosciences CLBS	254 K	-	-16.75 %	$ 25.8 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	15.9 M	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Editas Medicine EDIT	186 M	$ 2.91	-3.0 %	$ 258 M	USA
Edesa Biotech EDSA	2.6 M	$ 17.35	-5.06 %	$ 55.5 M	USA
Dynavax Technologies Corporation DVAX	218 M	-	-	$ 2.02 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.03	-5.02 %	$ 4.99 M	Israel
Eiger BioPharmaceuticals EIGR	31.9 M	-	-9.21 %	$ 2.55 M	USA
Eloxx Pharmaceuticals ELOX	5.24 M	-	-5.68 %	$ 8.28 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Evogene Ltd. EVGN	5.36 M	$ 0.79	1.66 %	$ 27.9 M	Israel
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Galmed Pharmaceuticals Ltd. GLMD	44 K	$ 0.57	0.07 %	$ 2.46 M	Israel